The purpose of this study is to determine whether local injection of bevacizumab might halt
and or cause regression of pterygium growth. This may enable earlier treatment and
prevention of pterygium growth into the patient's line of sight thereby limiting the need
for surgery and improving quality of life for patients with pterygia.
- 19 years of age and older
- Diagnosis of pterygia
- healthy enough to make scheduled follow-up visits
- Women of childbearing potential and males who plan to father a child during their
participation in the study will be excluded from the study.